What is the current Single Cell Multiomics market size?

The Single Cell Multiomics market size is approximately USD 1.2 billion as of 2023.

What is the future outlook for the Single Cell Multiomics market growth?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What challenges does the Single Cell Multiomics market face?

High costs and lack of standardization are significant challenges for the market.

Which regions are leading the Single Cell Multiomics market?

North America and Europe are the leading regions due to high investment in research.

Who are the top companies in the Single Cell Multiomics market?

Top companies include Illumina, Thermo Fisher, and Becton Dickinson.

What future opportunities exist in the Single Cell Multiomics market?

Opportunities exist in cancer research, immunology, and regenerative medicine applications.

How does technology impact the Single Cell Multiomics market?

Advances in sequencing and analytical technologies drive market growth and innovation.

What is the current regulatory landscape for the Single Cell Multiomics market?

Regulatory frameworks vary by region, with a focus on ensuring safety and efficacy.

How will the Single Cell Multiomics market evolve in the next 5 years?

The market will evolve through increased adoption of multiomic approaches and integration with AI.

Single Cell Multiomics Strategic Analysis & Growth Outlook 2033

Single Cell Multiomics by Application (Oncology, Cell biology, Neurology, Immunology, Stem cell research), by Types (Single cell genomics, Single cell proteomics, Single cell transcriptomics, Single cell metabolomics), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Single Cell Multiomics Market Size | CAGR 15.2 Forecast 2033

Single Cell Multiomics Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Single Cell Multiomics Market Overview

The Single Cell Multiomics market refers to the field of research and analysis that focuses on the study of individual cells using multiple omics technologies, such as genomics, transcriptomics, and proteomics. As an executive-ready market, the Single Cell Multiomics market size is estimated to be around $1.8 billion in 2025, with a growth outlook that is expected to reach $6.5 billion by 2033, driven by a market forecast that indicates a compound annual growth rate (CAGR) of 18.5% during the forecast period. The industry expansion is primarily driven by the increasing adoption of single-cell multiomics technologies in research and development, as well as the growing demand for personalized medicine. The scope of the market includes various segments, such as genomics, transcriptomics, and proteomics, which are used in different applications, including cancer research, immunology, and neurology.

Loading chart…

The growth of the Single Cell Multiomics market is driven by several key forces, including technology shifts, such as the development of new omics technologies, regulations, such as the increasing demand for personalized medicine, and consumer behavior, such as the growing awareness of the importance of individualized healthcare. The largest region in the Single Cell Multiomics market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to be driven by the increasing adoption of single-cell multiomics technologies in research and development, as well as the growing demand for personalized medicine. Overall, the Single Cell Multiomics market is expected to experience significant growth and expansion during the forecast period, driven by the increasing demand for single-cell analysis and multiomics technologies.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	10x Genomics; Becton, Dickinson and Company; Berkeley Lights; BGI Genomics; Bio Rad Laboratories; Danaher Corporation (Cytiva Life Sciences); Dolomite Bio; Epicypher; Fluidigm Corporation; Illumina; Miltenyi Biotec B.V. & CO.; Mission Bio; Nanostring Technologies; Olink Holding AB (Olink Proteomics); Parse Bioscience; Qiagen N.V.; Takara Holdings Inc. Takara Bio Group; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Single Cell Multiomics market is poised for significant growth, driven by factors such as advancements in technology and increasing demand for personalized medicine. This section outlines the key dynamics influencing the Single Cell Multiomics market size and growth forecast.

Growth Drivers2 items

Advancements in single-cell analysis technologies have improved the accuracy and efficiency of multiomics research, driving growth in the Single Cell Multiomics market. The integration of artificial intelligence and machine learning algorithms has further enhanced data analysis capabilities, leading to increased adoption of these technologies.

The rising demand for personalized medicine and targeted therapies has fueled the need for single-cell multiomics research, as it enables the identification of specific cell types and their responses to different treatments, thereby informing treatment strategies and contributing to the growth forecast of the Single Cell Multiomics market.

Restraints2 items

The high cost of equipment and reagents required for single-cell multiomics research is a significant restraint, limiting the accessibility of these technologies to smaller research institutions and emerging markets, and potentially hindering the growth of the Single Cell Multiomics market size.

The complexity of data analysis and interpretation in single-cell multiomics research can be a barrier to adoption, as it requires specialized expertise and infrastructure, which may not be readily available in all research settings, affecting the overall growth forecast of the Single Cell Multiomics market.

Opportunities2 items

The increasing collaboration between academia and industry is creating new opportunities for single-cell multiomics research, enabling the translation of basic research into clinical applications and driving growth in the Single Cell Multiomics market. This collaboration can facilitate the development of new technologies and therapies, further expanding the market size.

The expansion into new applications, such as cancer research and regenerative medicine, is providing a significant opportunity for growth in the Single Cell Multiomics market, as single-cell multiomics technologies can provide valuable insights into the biology of these diseases and enable the development of novel therapies, contributing to the growth forecast.

Challenges2 items

The standardization of protocols and data analysis methods is a significant challenge in single-cell multiomics research, as the lack of standardization can limit the comparability of results across different studies, affecting the overall growth of the Single Cell Multiomics market size and growth forecast.

The regulatory framework governing single-cell multiomics research is still evolving, and uncertainty surrounding the regulation of these technologies can create challenges for researchers and companies operating in the Single Cell Multiomics market, potentially hindering the market's growth forecast.

Market Segmentation

Loading chart…

The Single Cell Multiomics segmentation by application is a crucial aspect of understanding the market. This segmentation categorizes the market into various application areas, including cancer research, immunology, neurology, and other diseases. Each application area contributes significantly to the overall Single Cell Multiomics market size, with cancer research being the largest segment. The application segment is expected to drive the market growth due to the increasing demand for personalized medicine and targeted therapies.

The Single Cell Multiomics market can also be segmented by types, which includes single-cell RNA sequencing, single-cell DNA sequencing, and single-cell proteomics. These types are sub-categorized into various subtypes, such as scRNA-seq and snRNA-seq under single-cell RNA sequencing. Understanding the market taxonomy of Single Cell Multiomics is essential to identify the growth opportunities and trends in the market. The types segment is expected to witness significant growth due to the advancements in sequencing technologies and the increasing adoption of single-cell analysis in research and diagnostics.

Single Cell Multiomics Segmentation Breakdown11 items

Application

Oncology

Cell biology

Neurology

Immunology

Stem cell research

Types

Single cell genomics

Single cell proteomics

Single cell transcriptomics

Single cell metabolomics

Regional Insights

Loading chart…

The Single Cell Multiomics market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The Asia Pacific region is anticipated to be the fastest-growing, driven by increasing investments in research and development, favorable government policies, and a growing emphasis on precision medicine.

Key drivers for North America include high adoption rates of single-cell multiomics technologies, significant investments in research and development, and a well-established infrastructure. In Europe, key drivers include a strong focus on research and development, favorable regulatory policies, and a high level of ecosystem maturity. The Asia Pacific region is driven by growing demand for precision medicine, increasing investments in healthcare infrastructure, and a large and diverse patient population. Latin America and Middle East & Africa are driven by growing investments in healthcare, increasing adoption of single-cell multiomics technologies, and a rising focus on research and development.

The regional forecast for the Single Cell Multiomics market indicates a strong growth trajectory, with the Asia Pacific region expected to drive market growth. Factors such as demographics, infrastructure, and ecosystem maturity will play a crucial role in shaping the market growth in each region. As the market continues to evolve, it is essential to monitor the regional trends and developments to capitalize on emerging opportunities.

Competitive Landscape

The Single Cell Multiomics market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Single Cell Multiomics competitive landscape is driven by key competitive levers, including certifications and regulatory approvals. Global players are focusing on expanding their product portfolios and strengthening their distribution channels, while local companies are concentrating on regional expansion and customization.

Companies in the Single Cell Multiomics market are adopting various strategies to differentiate themselves, including M&A, partnerships, and product launches. Common challenges faced by these companies include margin pressure, compliance costs, and supply chain risks. To stay competitive, companies are focusing on technology innovation, service model enhancement, and channel strength. The following companies are implementing strategies to stay ahead in the market:

10x Genomics: innovation pipeline

Becton, Dickinson and Company: regional expansion

Berkeley Lights: premium pricing

BGI Genomics: local manufacturing

Bio Rad Laboratories: OEM tie-ups

Danaher Corporation: vertical integration

Key Single Cell Multiomics Companies18 items

10x Genomics

Becton, Dickinson and Company

Berkeley Lights

BGI Genomics

Bio Rad Laboratories

Danaher Corporation (Cytiva Life Sciences)

Dolomite Bio

Epicypher

Fluidigm Corporation

Illumina

Miltenyi Biotec B.V. & CO.

Mission Bio

Nanostring Technologies

Olink Holding AB (Olink Proteomics)

Parse Bioscience

Qiagen N.V.

Takara Holdings Inc. Takara Bio Group

Thermo Fisher Scientific

Market Ecosystem

The Single Cell Multiomics ecosystem encompasses a complex network of stakeholders, spanning from upstream technology providers to downstream end users. This ecosystem can be broadly categorized into three main segments: upstream, midstream, and downstream, with value created and captured through the interactions between technology providers, integrators, channels, and end users. The Single Cell Multiomics ecosystem is characterized by a value chain analysis that highlights the interdependencies between various stakeholders.

Raw material suppliers — provide reagents and consumables

Technology providers — develop and manufacture instrumentation

System integrators — design and implement multiomics workflows

Distributors — supply products to research institutions and labs

Service providers — offer training, maintenance, and support services

End users — researchers, scientists, and clinicians utilizing multiomics technologies

Regulators — establish standards and guidelines for multiomics research and applications

The flow of value within the Single Cell Multiomics ecosystem is influenced by control points, such as regulatory approvals and standards, which can impact the adoption of new technologies. Dependency risks, including input constraints and interoperability requirements, can also affect the ecosystem's dynamics. Moreover, the ecosystem's structure and interactions can vary by region, with different stakeholders and priorities influencing the development and implementation of Single Cell Multiomics technologies.

Recent Industry Insights

The Single Cell Multiomics market has witnessed significant developments over the last 12-18 months, shaping the industry's trajectory. Recent partnerships, such as collaborations between leading research institutions and biotechnology companies, have accelerated innovation in the field. Notable mergers and acquisitions have also occurred, with companies like Illumina expanding their portfolios to include single-cell multiomics capabilities. Furthermore, product and technology launches, such as advancements in single-cell sequencing and multiomics analysis software, have improved the efficiency and accuracy of single-cell multiomics research.

These developments have contributed to the evolution of Single Cell Multiomics industry trends, with a growing focus on personalized medicine, cancer research, and regenerative medicine. Funding rounds and expansions have also supported the growth of startups and established companies in the market, driving advancements in single-cell multiomics technologies and applications. As the industry continues to mature, regulatory changes and shifts in consumer and enterprise trends are expected to play a crucial role in shaping the future of single-cell multiomics research and development.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Single Cell Multiomics market. The Single Cell Multiomics market outlook is highly attractive, driven by the increasing adoption of single-cell analysis in research and diagnostics. The competitive intensity is moderate, with key players investing heavily in research and development to stay ahead. The long-term outlook is promising, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with advancements in technologies such as single-cell sequencing and multi-omic data integration. The demand-supply balance is currently skewed towards demand, with key risk factors including high equipment costs and limited standardization. Overall, the Single Cell Multiomics market presents a lucrative opportunity for investors and players, with a strong potential for growth and innovation.

11 items

1. Executive Summary

2. Single Cell Multiomics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Single Cell Multiomics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Single Cell Multiomics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Oncology

6.1.2. Cell biology

6.1.3. Neurology

6.1.4. Immunology

6.1.5. Stem cell research

6.2. Global Single Cell Multiomics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Single cell genomics

6.2.2. Single cell proteomics

6.2.3. Single cell transcriptomics

6.2.4. Single cell metabolomics

6.3. Global Single Cell Multiomics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Single Cell Multiomics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Single Cell Multiomics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Single Cell Multiomics Market Competition by Key Manufacturers

8.1. Global Single Cell Multiomics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Single Cell Multiomics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. 10x Genomics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Becton, Dickinson and Company

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Berkeley Lights

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. BGI Genomics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Bio Rad Laboratories

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Danaher Corporation (Cytiva Life Sciences)

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Dolomite Bio

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Epicypher

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Fluidigm Corporation

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Illumina

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Miltenyi Biotec B.V. & CO.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Mission Bio

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Nanostring Technologies

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Olink Holding AB (Olink Proteomics)

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Parse Bioscience

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Qiagen N.V.

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Takara Holdings Inc. Takara Bio Group

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Thermo Fisher Scientific

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Single Cell Multiomics Market

Figure 4: Global Single Cell Multiomics Market: Drivers

Figure 5: Global Single Cell Multiomics Market: Challenges

Figure 6: Global Single Cell Multiomics Market: Trends

Figure 7: Global Single Cell Multiomics Market: Opportunity

Figure 8: Global Single Cell Multiomics Market: Restraint

Figure 9: Global Single Cell Multiomics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Single Cell Multiomics Market Value (USD Million) By Region

Figure 15: Global Single Cell Multiomics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Single Cell Multiomics Market Value (USD Million) By Region

Figure 23: Global Single Cell Multiomics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global Single Cell Multiomics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Single Cell Multiomics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Single Cell Multiomics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Single Cell Multiomics Market Value (USD Million) By Region

Table 10: Global Single Cell Multiomics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Single Cell Multiomics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Single Cell Multiomics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Single Cell Multiomics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: 10x Genomics Basic Information And Sales Area

Table 31: 10x Genomics. Products Portfolio

Table 32: Becton, Dickinson and Company Basic Information And Sales Area

Table 33: Becton, Dickinson and Company. Products Portfolio

Table 34: Berkeley Lights Basic Information And Sales Area

Table 35: Berkeley Lights. Products Portfolio

Table 36: BGI Genomics Basic Information And Sales Area

Table 37: BGI Genomics. Products Portfolio

Table 38: Bio Rad Laboratories Basic Information And Sales Area

Table 39: Bio Rad Laboratories. Products Portfolio

Table 40: Danaher Corporation (Cytiva Life Sciences) Basic Information And Sales Area

Table 41: Danaher Corporation (Cytiva Life Sciences). Products Portfolio

Table 42: Dolomite Bio Basic Information And Sales Area

Table 43: Dolomite Bio. Products Portfolio

Table 44: Epicypher Basic Information And Sales Area

Table 45: Epicypher. Products Portfolio

Table 46: Fluidigm Corporation Basic Information And Sales Area

Table 47: Fluidigm Corporation. Products Portfolio

Table 48: Illumina Basic Information And Sales Area

Table 49: Illumina. Products Portfolio

Table 50: Miltenyi Biotec B.V. & CO. Basic Information And Sales Area

Table 51: Miltenyi Biotec B.V. & CO.. Products Portfolio

Table 52: Mission Bio Basic Information And Sales Area

Table 53: Mission Bio. Products Portfolio

Table 54: Nanostring Technologies Basic Information And Sales Area

Table 55: Nanostring Technologies. Products Portfolio

Table 56: Olink Holding AB (Olink Proteomics) Basic Information And Sales Area

Table 57: Olink Holding AB (Olink Proteomics). Products Portfolio

Table 58: Parse Bioscience Basic Information And Sales Area

Table 59: Parse Bioscience. Products Portfolio

Table 60: Qiagen N.V. Basic Information And Sales Area

Table 61: Qiagen N.V.. Products Portfolio

Table 62: Takara Holdings Inc. Takara Bio Group Basic Information And Sales Area

Table 63: Takara Holdings Inc. Takara Bio Group. Products Portfolio

Table 64: Thermo Fisher Scientific Basic Information And Sales Area

Table 65: Thermo Fisher Scientific. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global Single Cell Multiomics Market Value (USD Million) By Region

Table 71: Global Single Cell Multiomics Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Single Cell Multiomics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	10x Genomics; Becton, Dickinson and Company; Berkeley Lights; BGI Genomics; Bio Rad Laboratories; Danaher Corporation (Cytiva Life Sciences); Dolomite Bio; Epicypher; Fluidigm Corporation; Illumina; Miltenyi Biotec B.V. & CO.; Mission Bio; Nanostring Technologies; Olink Holding AB (Olink Proteomics); Parse Bioscience; Qiagen N.V.; Takara Holdings Inc. Takara Bio Group; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options